Point of Care (POC) HIV Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 150 SKU: IRTNTR76044

Point of Care (POC) HIV Testing Market Analysis Report 2023-2027:

The global point of care (POC) HIV testing market size is estimated to grow by USD 290.77 million at a CAGR of 2.91% between 2022 and 2027. 

The major key driver of the POC HIV testing market is the early detection and the increasing prevalence of HIV worldwide. HIV is referred to as a viral infection that depletes the immune system, leading to acquired immunodeficiency syndrome (AIDS). The significant reasons why the increasing HIV prevalence drives the demand for POC HIV testing and point of care HIV testing market growth: Increasing HIV Incidence: The number of new HIV infections globally continues to be a major concern. Expanding High-Risk Populations: Certain population groups, such as men who have sex with men (MSM), intravenous drug users, and sex workers, are at a higher risk of contracting HIV. Limited Access to Prevention Measures: Limited access to preventive measures, such as comprehensive sex education, condoms, clean needle exchange programs, and pre-exposure prophylaxis (PrEP), can result in a higher rate of new HIV infections in some regions. The demand for POC HIV testing grows to address existing infections as prevention measures are not universally available or accessible. Such factors are expected to collectively contribute to the increasing prevalence of HIV and drive the demand for POC HIV testing and, in turn, fuel the growth of the market in focus during the forecast period.

Technavio has segmented the market into product, end-user, and geography

  • The Product  segment is classified into POC HIV testing equipment and POC HIV testing reagents
  • The end-user segment is classified into diagnostic labs, hospitals and clinics, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario. 

What will be the size of the POC HIV Testing Market During the Forecast Period?

To learn more about this report, Request Free Sample

POC HIV Testing Market Segmentation by Product, End-user and Geography Analysis

Product Analysis 

POC HIV Testing Equipment 

The market share growth by the POC HIV testing equipment segment will be significant during the forecast period. The devices and instruments used to conduct the HIV test at or near the location where the patient is receiving care shall be referred to as POC HIV testing equipment. Rapid HIV test kits, POC HIV viral load tests, testing systems, and POC CD4 count devices are also included in this equipment. POC HIV testing equipment plays a vital role in expanding access to testing, improving early diagnosis, and increasing linkage to care, particularly in settings with limited laboratory infrastructure or in community-based testing programs.

Get a glance at the market contribution of various segments View a PDF Sample

The POC HIV testing equipment segment was the largest segment and was valued at USD 1,548.81 million in 2017. POC testing equipment has further enhanced the way diagnostics and clinical services are performed. Early HIV diagnostics and rapid initiation of treatment are also important methods implemented by several stakeholders to prevent the spread of HIV. Consequently, technological advances in the form of low-cost rapid POC HIV test equipment have transformed the diagnosis and disease management of HIV.  The increasing focus on preventive and early diagnosis programs has boosted the demand for POC HIV testing equipment. Rapid testing can aid in identifying HIV infections at an early stage, enabling timely medical interventions and reducing the risk of disease progression. Thus, the above-mentioned benefits of POC HIV testing equipment will increase its demand and the increasing prevalence of HIV worldwide will spur the growth of the global POC HIV testing market through the POC HIV testing equipment segment during the forecast period.

End-user Analysis

Diagnostic labs

With the growing demand for medical services in the healthcare sector, diagnostic labs have grown exponentially over the years. The increased awareness among the population pertaining to the benefits of early detection of POC HIV testing, the availability of a wide range of POC HIV testing, and the growing number of healthcare settings offerings POC HIV testing are some of the major attributes that are contributing to the demand for HIV diagnostics services involving POC HIV testing. With the availability of a wide range of POC HIV testing across multiple diagnostic labs in both developed and developing nations, a rising number of people are choosing POC HIV testing. This, in turn, will drive the diagnostics lab segment and, as a result, the

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

Asia is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Another region offering significant growth opportunities to vendors is North America. In this region, the point of care (POC) HIV testing market has experienced major growth and innovation in recent years. The expansion of the regional POC HIV testing markets is due to advances in medical research, improved healthcare infrastructure, and increased awareness about HIV/AIDS. North America is a major market for POC HIV testing, encompassing the US, Canada, and Mexico. 

Moreover, the government and non-government organizations in the US includes regular health check-ups as a part of their wellness programs, thereby augmenting the demand for POC HIV testing which in turn propels the POC HIV testing market growth.Furthermore, the Get Tested website service provided by the Centers for Disease Control and Prevention (CDC) enables people to find fast, free, and confidential testing centres near their desired locations in the US. The search tool on the website allows users to find desired locations and clinics with the help of area zip codes, thereby providing people with information about HIV testing locations. Such factors are expected to drive the market in this region during the forecast period. 

In 2020, the COVID-19 pandemic severely impacted the regional POC HIV testing market. Due to the temporary suspension of diagnostic services as well as procedures, the pandemic led to a decline in the use of POC HIV testing in regional healthcare facilities which negatively impacted the point of care (POC) HIV testing market. Nevertheless, the initiation of COVID-19 vaccination and the lifting of lockdown restrictions led to the gradual resumption of various clinical procedures, which were postponed. As a result, there is an increase in demand for POC HIV testing in Q1 2021 due to the resumption of regular diagnostic services and treatments in North America. Therefore, the regional POC HIV testing market is expected to experience growth during the forecast period.

Key POC HIV Testing Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Abbott Laboratories - The company offers POC HIV testing such as Determine HIV 1 or 2 AG Combo.

  • AltraTech Ltd.
  • Becton Dickinson and Co.
  • binx health inc.
  • bioMerieux SA
  • Cochrane
  • Community Pharmacy England
  • CVS Health Corp.
  • Danaher Corp.
  • DrSafeHands
  • F. Hoffmann La Roche Ltd.
  • Island Health
  • J. Mitra and Co. Pvt. Ltd.
  • MH Sub I LLC
  • Orchard Healthcare Pvt. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

POC HIV Testing Market: Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Significant POC HIV Testing Market Trends

The rise in awareness programs for HIV testing is an emerging trend shaping the market growth. The provision of HIV counselling and testing plays an imperative part in growing awareness of HIV, as it has a higher probability of declining the rate of new infections. With the aim to prevent the spread of HIV, several national and international organizations have been set up across the globe. For instance, the American Institutes for Research (AIR) is a not-for-profit organization that works toward bringing the most effective ideas and approaches to enhance the quality of life.  In order to integrate HIV testing into primary health care, it offers healthcare professionals a variety of instruments and resources.

However, such a strategy incorporates three major goals such as the reduction of new HIV infections, expanding access to care for people living with HIV, and lowering HIV-related health threats. Therefore, the growing awareness about HIV infection and its subsequent treatment through several government and private organizations have resulted in higher adoption of POC HIV testing, thereby will drive the market growth during the forecast period. 

Major POC HIV Testing Market Challenges

Limited healthcare services in developing and underdeveloped nations is a significant challenge hindering the market growth. A large population in developing regions such as Asia-Pacific, the Middle East, and Africa neither access to healthcare facilities nor have adequate knowledge about health concerns. Such a trend is prevalent due to a lack of financial and human resources, which is a significant barrier to public health promotion, hence rising the HIV-infected population. Developing countries such as Algeria, Kenya, Afghanistan, and Bangladesh lack technology, infrastructure, and adequate policies to deliver efficient healthcare services.

Also, many people have a stigma related to HIV testing due to a lack of education, such as the misconception that HIV is not a serious threat and embarrassment about a physical examination. This leads to the avoidance of HIV testing and treatment of HIV. The prevalence of HIV causes high rates of mortality and morbidity, and a lack of financial resources for infrastructure and health facilities may impede market growth during the forecast period.

Buy Now Full Report and Discover More

Key POC HIV Testing Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global POC HIV Testing Market Customer Landscape

Segment Overview

The POC HIV testing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Million, 2017 - 2027)
    • POC HIV testing equipment
    • POC HIV testing reagents
  • End-user Outlook (USD Million, 2017 - 2027)
    • Diagnostic labs
    • Hospitals and clinics
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World
      • Australia
      • Brazil
      • Argentina

POC HIV Testing Market Scope

Report Coverage

Details

Page number

150

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 2.91%

Market growth 2023-2027

USD 290.77 million

Market structure

Fragmented

YoY growth 2022-2023(%)

2.65

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

Asia at 33%

Key countries

US, Germany, France, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, AltraTech Ltd., Becton Dickinson and Co., binx health inc., bioMerieux SA, Cochrane, Community Pharmacy England, CVS Health Corp., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Island Health, J. Mitra and Co. Pvt. Ltd., MH Sub I LLC, Orchard Healthcare Pvt. Ltd., OraSure Technologies Inc., SHINE SA, Walter de Gruyter GmbH, Yashoda Hospitals, and bioLytical Laboratories Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this POC HIV Testing Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the POC HIV testing market between 2023 and 2027
  • Precise estimation of the POC HIV testing market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of POC HIV testing market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global POC HIV testing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global poc hiv testing market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 POC HIV testing equipment - Market size and forecast 2022-2027
      • Exhibit 34: Chart on POC HIV testing equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on POC HIV testing equipment - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on POC HIV testing equipment - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on POC HIV testing equipment - Year-over-year growth 2022-2027 (%)
    • 6.4 POC HIV testing reagents - Market size and forecast 2022-2027
      • Exhibit 38: Chart on POC HIV testing reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on POC HIV testing reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on POC HIV testing reagents - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on POC HIV testing reagents - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Diagnostic labs - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Diagnostic labs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Diagnostic labs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Diagnostic labs - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Diagnostic labs - Year-over-year growth 2022-2027 (%)
    • 7.4 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 France - Market size and forecast 2022-2027
      • Exhibit 95: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 111: Abbott Laboratories - Overview
              • Exhibit 112: Abbott Laboratories - Business segments
              • Exhibit 113: Abbott Laboratories - Key news
              • Exhibit 114: Abbott Laboratories - Key offerings
              • Exhibit 115: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 116: Becton Dickinson and Co. - Overview
              • Exhibit 117: Becton Dickinson and Co. - Business segments
              • Exhibit 118: Becton Dickinson and Co. - Key news
              • Exhibit 119: Becton Dickinson and Co. - Key offerings
              • Exhibit 120: Becton Dickinson and Co. - Segment focus
            • 12.5 binx health inc.
              • Exhibit 121: binx health inc. - Overview
              • Exhibit 122: binx health inc. - Product / Service
              • Exhibit 123: binx health inc. - Key offerings
            • 12.6 bioLytical Laboratories Inc.
              • Exhibit 124: bioLytical Laboratories Inc. - Overview
              • Exhibit 125: bioLytical Laboratories Inc. - Product / Service
              • Exhibit 126: bioLytical Laboratories Inc. - Key offerings
            • 12.7 bioMerieux SA
              • Exhibit 127: bioMerieux SA - Overview
              • Exhibit 128: bioMerieux SA - Product / Service
              • Exhibit 129: bioMerieux SA - Key news
              • Exhibit 130: bioMerieux SA - Key offerings
            • 12.8 Cochrane
              • Exhibit 131: Cochrane - Overview
              • Exhibit 132: Cochrane - Product / Service
              • Exhibit 133: Cochrane - Key offerings
            • 12.9 CVS Health Corp.
              • Exhibit 134: CVS Health Corp. - Overview
              • Exhibit 135: CVS Health Corp. - Business segments
              • Exhibit 136: CVS Health Corp. - Key news
              • Exhibit 137: CVS Health Corp. - Key offerings
              • Exhibit 138: CVS Health Corp. - Segment focus
            • 12.10 Danaher Corp.
              • Exhibit 139: Danaher Corp. - Overview
              • Exhibit 140: Danaher Corp. - Business segments
              • Exhibit 141: Danaher Corp. - Key news
              • Exhibit 142: Danaher Corp. - Key offerings
              • Exhibit 143: Danaher Corp. - Segment focus
            • 12.11 DrSafeHands
              • Exhibit 144: DrSafeHands - Overview
              • Exhibit 145: DrSafeHands - Product / Service
              • Exhibit 146: DrSafeHands - Key offerings
            • 12.12 F. Hoffmann La Roche Ltd.
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 148: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 149: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.13 Island Health
              • Exhibit 152: Island Health - Overview
              • Exhibit 153: Island Health - Product / Service
              • Exhibit 154: Island Health - Key offerings
            • 12.14 J. Mitra and Co. Pvt. Ltd.
              • Exhibit 155: J. Mitra and Co. Pvt. Ltd. - Overview
              • Exhibit 156: J. Mitra and Co. Pvt. Ltd. - Product / Service
              • Exhibit 157: J. Mitra and Co. Pvt. Ltd. - Key offerings
            • 12.15 MH Sub I LLC
              • Exhibit 158: MH Sub I LLC - Overview
              • Exhibit 159: MH Sub I LLC - Product / Service
              • Exhibit 160: MH Sub I LLC - Key offerings
            • 12.16 OraSure Technologies Inc.
              • Exhibit 161: OraSure Technologies Inc. - Overview
              • Exhibit 162: OraSure Technologies Inc. - Business segments
              • Exhibit 163: OraSure Technologies Inc. - Key offerings
              • Exhibit 164: OraSure Technologies Inc. - Segment focus
            • 12.17 Walter de Gruyter GmbH
              • Exhibit 165: Walter de Gruyter GmbH - Overview
              • Exhibit 166: Walter de Gruyter GmbH - Product / Service
              • Exhibit 167: Walter de Gruyter GmbH - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              poc hiv testing market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis